#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bulbospinal muscular atrophy congenital Diffuse large B-cell lymphoma recurrent Dementia with Lewy bodies Cholangiosarcoma Multifocal motor neuropathy Congenital nephrogenic diabetes insipidus Precursor T-lymphoblastic lymphoma/leukaemia recurrent Cholangitis sclerosing Anal cancer Inclusion body myositis Breast cancer Cold type haemolytic anaemia Sickle cell anaemia Myelodysplastic syndrome Extraskeletal ossification More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis – Treatment Angiosarcoma recurrent – Basic Information Mucopolysaccharidosis – Basic Information Malignant fibrous histiocytoma – Trials in Disease Hepatoblastoma – Diagnostics Mucopolysaccharidosis III – Trials in Disease Sarcoma Ocular melanoma – Life with Disease IgA nephropathy – Trials in Disease Encephalitis autoimmune – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Isoleucine Icosapent Ethyl Inupadenant Buparlisib Tildacerfont Sodium Zirconium Cyclosilicate Paracetamol Ph. Eur. Isoflurane Magnesium Citrate Phenylephrine ALG-000184 Granisetron HUMAN COAGULATION FACTOR XIII IMEROPRUBART Bempedoic Acid Vibostolimab Dc-806 Naproxen Sodium NALMEFENE HYDROCHLORIDE Efepoetin Alfa More therapies…

    Learn about Your Condition

    Premature rupture of membranes Acquired haemophilia Stress urinary incontinence Immune system disorder Migraine without aura Lung adenocarcinoma stage IV Neuralgia Orthostatic hypotension Non-small cell lung cancer Depression Pharyngeal cancer stage I Adenomyosis Acute myeloid leukaemia Peripheral artery restenosis Chronic granulomatous disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Departemental Vendee

Centre Hospitalier Departemental Vendee

Boulevard Stephane Moreau, La Roche sur Yon, 85925, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Radiotherapy with Cetuximab and Xevinapant for Patients with Advanced Head and Neck Cancer Unfit for High-Dose Cisplatin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Xevinapant
    • Cetuximab
    France

  • Study of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Olaparib
    • Pembrolizumab
    France Germany Italy Latvia Poland Romania +2

  • Study on Stopping Tocilizumab for Patients with Giant Cell Arteritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Giant cell arteritis
    Investigated Drugs:
    • Tocilizumab
    France

  • Study Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma stage IV
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    • Sunitinib
    Austria Belgium Czechia Denmark Finland France +7

  • Study on Dobutamine and Glucose for Patients with Septic Cardiomyopathy and Low Blood Flow

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Glucose Monohydrate
    France

  • Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan
    France Italy

  • Study Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Tivozanib
    • Nivolumab
    Belgium Czechia France Germany Italy Poland +2

  • Study on Preventing Low Calcium Levels After Thyroid Surgery with Preoperative Cholecalciferol Supplementation for Patients Undergoing Total Thyroidectomy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Thyroidectomy
    • Hypocalcaemia
    Investigated Drugs:
    • Colecalciferol
    France

  • Study on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Bortezomib
    • Dexamethasone
    • Isatuximab
    France

  • Study on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Evolocumab
    France Germany Italy Poland Spain
Previous Page
1 … 18 19 20 21
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!